SUMMARY A 40 year old man with a history of myocardial infarction and hypertension presented with transient cerebral ischaemic attacks, aortic regurgitation, a raised erythrocyte sedimentation rate, and thrombocytopenia. The anticardiolipin syndrome was diagnosed and he was treated with prednisolone and warfarin. He died two years later after the development of acute heart failure. At necropsy his heart showed widespread arteriolar thrombosis without vasculitis, recanalised large vessel occlusion, and a "post-inflammatory" valvulitis of the aortic valve.
The term anticardiolipin syndrome is a recent introduction but the disease itself is by no means new. False positive results on serological testing for syphilis were reported in a few patients with systemic lupus erythematosus long before lupus erythematosus cells and other immunological features were detected.' These patients and those with the "lupus anticoagulant" were only recently recognised as forming a clinically distinct group that was liable to thrombosis, thrombocytopenia, and recurrent abortion. Although they are often negative for antinuclear factor,2 they have high titres of antibodies to phospholipids, which for convenience are measured as cardiolipin antibodies. These phospholipid antibodies may play a part in the thrombotic com- plications' but they also interfere with in vitro coagulation tests, hence the confusing term "lupus anticoagulant". Systemic lupus erythematosus and the anticardiolipin syndrome are now regarded as separate but overlapping parts of the autoimmune spectrum.
Recent reports indicate that phospholipid antibodies are common both in young survivors of myocardial infarction4 and after coronary artery bypass grafting5: furthermore, their presence is associated with recurrent thrombotic episodes. Car Cross sectional echocardiography shQwed thickening of the non-coronary cusp of the aortic valve. A biopsy specimen of skin and muscle taken from an area of livedo reticularis showed evidence of venous thrombosis in the subcutis but immunofluorescence was non-specific. A renal biopsy specimen showed only ischaemic changes without evidence of vasculitis or glomerulonephritis.
He was treated with warfarin and prednisolone (30 mg/day) and his haemoglobin and erythrocyte sedimentation rate returned to normal although concentrations of cardiolipin antibody and C3d remained high. Over the next two years he remained well with no change in the clinical signs or cardiothoracic ratio on chest x ray, despite a reduction in the dose of prednisolone to 7-5 mg/day. He died suddenly at home after a week of increasing breathlessness and fatigue.
At necropsy the heart was enlarged (580 g). The tricuspid, pulmonary, and mitral valves were normal. The aortic valve (fig 1) had thickened and fibrotic cusps with commissural fusion between the left and non-coronary cusps. There was a small fibrous nodule in the middle of the free margin of the nonMurphy, Leach coronary cusp, with cusp retraction resulting in functional aortic incompetence. The left ventricle was dilated and hypertrophied (280 g). There was an area of fibrosis in the anterior wall consistent with a previous infarct. Coronary angiography after death showed extensive recanalisation of the left anterior descending artery and a low grade stenosis on the posterior right coronary artery.
Histologically the aortic cusps were thickened and fibrosed. The nodule on the non-coronary cusp was composed of dense fibrous tissue with organising platelet thrombus at the free margin. The features were those of a non-specific "post-inflammatory" valvulitis. The left anterior descending artery showed extensive recanalisation at the site of a small underlying fibrous plaque. Stenosis of the right coronary artery was caused by a small fibrous plaque with overlying platelet thrombus: there was no evidence of plaque fissuring in any of the levels examined.
The most striking finding was the presence of multiple platelet thombi within small intramyocardial arterioles ( fig 2) ; these were present within the territories of all three coronary arteries. Some were recent while others showed evidence of organisation and recanalisation. Associated with these vascular occlusions were multiple microinfarcts, some of which were recent while others were organised fibrous scars. There were multiple microinfarcts with extensive small vessel occlusion and recanalisation in the brain and kidneys. There was only slight atheroma of the aorta but there were several intimal plaques measuring up to 5 cm in diameter in the ascending aorta and arch. Histologically these showed fibrous intimal thickening with overlying platelet thrombus, which in places was being incorporated into the intima. Both lungs showed severe pulmonary oedema and there were bilateral adrenal haemorrhages that were thought to be an agonal event, possibly related to anticoagula- The syndrome is characterised by thrombosis, thrombocytopenia, and recurrent abortion; but livedo reticularis, epilepsy, and both systemic and pulmonary hypertension are associated features.
Renal disease when present is usually vascular in origin.
Two previous case reports in the British Heart Journal have described the thrombotic complications Murphy, Leach of phospholipid antibodies in patients with systemic lupus erythematosus.89 But while systemic lupus erythematosus and the anticardiolipin syndrome are closely related conditions, which may coexist in the same patient, each may also occur in isolation and the differing clinical and immunological features justify their distinction.2 This is illustrated by the current case where neither antinuclear factor nor DNA antibodies were detected.
An association between the anticardiolipin syndrome and both aortic and mitral regurgitation is now recognised.'0 The heart is often affected in classic systemic lupus erythematosus" but a recent echocardiographic series suggests that endocarditis, valve thickening, and unexplained impairment of left ventricular function occur almost exclusively in those who also have cardiolipin antibodies.'2 In the present case, aortic valve histology showed features of a post-inflammatory valulitis; these changes are non-specific and their association with cardiolipin antibodies remains speculative.
The most important finding at necropsy was widespread microvascular thrombosis affecting myocardial, cerebral, and renal arterioles and resulting in diffuse ischaemic damage. We are not aware of any previous reports of such extensive thrombus of small vessels in the absence of clinical or immunological features of systemic lupus erythematosus. This case extends the range of cardiac lesions associated with cardiolipin antibodies and highlights the typical clinical features of the syndrome. 
